SERMs are also applied during "transition off TRT" to help reactivate the HPG axis and accelerate recovery of sperm production. These agents are especially useful in younger men with mild testosterone deficiency who want to maintain natural fertility. Though costly, it significantly improves sperm parameters in men with secondary hypogonadism. Recombinant FSH (rFSH) is used off-label in the United States for male infertility at doses of 75–150 IU three times per week. Serum LH and FSH levels were 101 ± 6% and 102 ± 3% of the control values in men in the sesame oil injection group and 91 ± 7% and 97 ± 4% of the control values in the 25 mg testosterone enanthate group, respectively. An injection every 10 to 12 days sustained the total inhibition of luteinizing hormone and azoospermia or severe (15. This led to a harsh suppression of gonadotropins and sperm production to azoospermia or less than 100,000 sperm/mL. An amount of 50 mg of testosterone enanthate per week led to severe oligozoospermia (with a concentration of 3]. However, if the testosterone treatment duration is longer than 3 years, recovery might take several years and the use of ancillary drugs to stimulate gonadotropins. Participants received 500 mg/month for 30 months and sperm parameters were monitored for up to 12 months post-cessation. After the first two injections of intramuscular testosterone undecanoate depot (Nebido®) separated by 6 weeks, azoospermia occurred.|As for primary hypogonadism, the nasal spray option seems to lead to solid improvements in serum testosterone levels while minimizing side effects on spermatogenesis. Another study gathering data from more than 1000 healthy men with normal sperm production investigated the effects of 30 months of injectable testosterone undecanoate on fertility outcomes . For people who want to get pregnant, doctors usually recommend waiting at least three months before trying, although as discussed above, some people have opted to try for pregnancy while still on testosterone, or after stopping for just a few weeks, as this case study demonstratesexternal link, opens in a new tab.|Testolactone and anastrozole led to similar adaptations, including serum testosterone levels, during treatment . The initial luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone levels were recorded at 0.53 ± 0.77 IU/L, 0.63 ± 0.61 IU/L, and 1.10 ± 1.90 ng/dL, respectively. The combination of pure FSH and [buy testosterone gel online](https://ex-pose.one/@katheriny1797?page=about) did not trigger spermatogenesis, and the sperm count significantly decreased to 0.3 ± 0.1 × 106/mL after 3 months and 0 after 6 months. Therefore, it is often used in combination with HCG to trigger spermatogenesis in patients with hypogonadotropic hypogonadism .|Fertility data is available for the use of concomitant use of human chorionic gonadotropin (HCG) and aromatase inhibitor (AI) therapy with TRT. Exogenous testosterone’s contraceptive effect occurs through its suppression of the HPG axis, preventing LH and FSH release and their respective gonadal functions (11). Low ITT levels result in an impaired blood-testis barrier permitting immune cells to enter the seminiferous tubules and attack autoantigenic germ cells reviewed by Walker (8). Unsurprisingly, inactivating mutations of the FSHR and LHR results in impaired fertility (3,4).|This hormonal imbalance disrupts intratesticular testosterone concentrations vital for sperm maturation, consequently contributing to fertility decline. Exogenous testosterone administration inhibits gonadotropin-releasing hormone (GnRH) secretion, reducing luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels, critical regulators of testicular function. TRT alone suppresses the hypothalamic-pituitary-gonadal axis, reducing intratesticular testosterone and impairing spermatogenesis. In our opinion, hypogonadal men seeking treatment without side effects on fertility should first consider HCG or clomiphene treatment. In the case of primary hypogonadism, post-cycle therapy might not be effective in restoring HPGA functions; therefore, freezing sperm is especially important in these individuals before starting TRT. Also, in the case of injectable [buy testosterone online no prescription](https://aiviu.app/@kellibeet1528?page=about) medications, before initiating TRT, it is recommended to freeze sperm at a sperm bank or fertility clinic. The duration of fertility recovery seems to be dependent on the dosage and length of the [buy testosterone online](http://175.27.229.211:3000/gabriellacurts) treatment.|Safety monitoring recommendations for men on testosterone therapy Clinically, most men on standard TRT develop azoospermia or severe oligospermia within three to six months. Understanding the physiology of suppression and the window of reversibility is the first step toward protecting spermatogenesis while maintaining hormonal health. In the United States alone, more than 3 million men are now using injectable testosterone formulations for clinically diagnosed hypogonadism.} Start by finding a qualified clinician who is knowledgeable in testosterone therapy. For example, some healthcare professionals require a well-documented history of gender dysphoria before prescribing or approving gender affirming interventions like hormone therapy. Your clinician may also have certain requirements before they will allow you to move forward with testosterone therapy. If you’re under age 18, you may be able to receive testosterone therapy with parental consent. Generally speaking, access to gender affirming care — which includes testosterone therapy — is limited to consenting adults ages 18 and older. Learn about the connection between infertility and age. The risk of infertility increases as you age. Infertility is a condition where you can’t get pregnant after one year of trying to conceive. Availability, access, and quality of interventions to address infertility remain a challenge in most countries. Only a healthcare provider can determine the cause and find the best treatment for you. Fortunately, there are many treatment options available for women who wish to begin or expand their family. Infertility is more common than you might think. A pregnancy can’t occur if anything in this process doesn’t happen. Infertility can affect anyone and has many causes. WHO recognizes that the provision of high-quality services for family-planning, including fertility care services, is one of the core elements of reproductive health. Once fertility policies are in place, it is essential to ensure that their implementation is monitored, and the quality of services is continually improved. Spermatogenesis depends on the pulsatile release of gonadotropins, follicle stimulating hormone (FSH), and luteinizing hormone (LH), from the pituitary, and their action on their cells in the testis. Male fertility and proper functioning of the HPG axis are closely intertwined. Some therapeutic strategies may even enhance the fertility potential of men with certain diagnoses. In male patients, even though promising results have been published, the usage of SERMs remains off-label. In this case, the addition of testosterone would negatively impact semen parameters. Therefore, if HCG is available, HCG alone should be used first, and the addition of testosterone should only be considered if serum testosterone does not increase to the target level. After [buy testosterone online without prescription](http://113.177.27.200:2033/vernlambert121) administration, LH and FSH were inhibited to 5% and 3% of baseline, respectively, and ITT was downregulated by 94% (1234 to 72 nmol/L) in the [buy testosterone supplements](http://www.flop.jp.org/bbs_font/bbs.cgi)/placebo group. The baseline serum testosterone level (14.1 nmol/L) was only 1.2% of the ITT level (1174 nmol/L). In addition, enabling laws and policies that regulate third party reproduction and ART are essential to ensure universal access without discrimination and [https://employ.co.il/](https://employ.co.il/employer/the-molecular-mechanism-of-sex-hormones-on-sertoli-cell-development-and-proliferation/) to protect and promote the human rights of all parties involved. Government policies could mitigate the many inequities in access to safe and effective fertility care. Infertility has significant negative social impacts on the lives of infertile couples and particularly women, who frequently experience violence, divorce, social stigma, emotional stress, depression, anxiety and low self-esteem. Inequities and disparities in access to fertility care services adversely affect the poor, unmarried, uneducated, unemployed and other marginalized populations. Infertility can negate the realization of these essential human rights (3). This preserves testicular stimulation while maintaining serum testosterone levels sufficient to relieve hypogonadal symptoms. Clinical studies from Fertility and Sterility (2024) and The Journal of Urology (2025) demonstrate that HCG co-therapy can preserve sperm counts in men receiving exogenous testosterone. It binds to LH receptors on Leydig cells, stimulating them to produce testosterone inside the testes maintaining the intratesticular concentration necessary for sperm production. Discussing it early allows clinicians and patients to plan interventions such as adding low-dose HCG during TRT to protect spermatogenesis without compromising symptom control. The American Urological Association’s 2025 update emphasizes that fertility preservation is part of informed consent for testosterone therapy.
SERMs are also applied during "transition off TRT" to help reactivate the HPG axis and accelerate recovery of sperm production. These agents are especially useful in younger men with mild testosterone deficiency who want to maintain natural fertility. Though costly, it significantly improves sperm parameters in men with secondary hypogonadism. Recombinant FSH (rFSH) is used off-label in the United States for male infertility at doses of 75–150 IU three times per week. Serum LH and FSH levels were 101 ± 6% and 102 ± 3% of the control values in men in the sesame oil injection group and 91 ± 7% and 97 ± 4% of the control values in the 25 mg testosterone enanthate group, respectively. An injection every 10 to 12 days sustained the total inhibition of luteinizing hormone and azoospermia or severe (15. This led to a harsh suppression of gonadotropins and sperm production to azoospermia or less than 100,000 sperm/mL. An amount of 50 mg of testosterone enanthate per week led to severe oligozoospermia (with a concentration of 3]. However, if the testosterone treatment duration is longer than 3 years, recovery might take several years and the use of ancillary drugs to stimulate gonadotropins. Participants received 500 mg/month for 30 months and sperm parameters were monitored for up to 12 months post-cessation. After the first two injections of intramuscular testosterone undecanoate depot (Nebido®) separated by 6 weeks, azoospermia occurred.|As for primary hypogonadism, the nasal spray option seems to lead to solid improvements in serum testosterone levels while minimizing side effects on spermatogenesis. Another study gathering data from more than 1000 healthy men with normal sperm production investigated the effects of 30 months of injectable testosterone undecanoate on fertility outcomes . For people who want to get pregnant, doctors usually recommend waiting at least three months before trying, although as discussed above, some people have opted to try for pregnancy while still on testosterone, or after stopping for just a few weeks, as this case study demonstratesexternal link, opens in a new tab.|Testolactone and anastrozole led to similar adaptations, including serum testosterone levels, during treatment . The initial luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone levels were recorded at 0.53 ± 0.77 IU/L, 0.63 ± 0.61 IU/L, and 1.10 ± 1.90 ng/dL, respectively. The combination of pure FSH and [buy testosterone gel online](https://ex-pose.one/@katheriny1797?page=about) did not trigger spermatogenesis, and the sperm count significantly decreased to 0.3 ± 0.1 × 106/mL after 3 months and 0 after 6 months. Therefore, it is often used in combination with HCG to trigger spermatogenesis in patients with hypogonadotropic hypogonadism .|Fertility data is available for the use of concomitant use of human chorionic gonadotropin (HCG) and aromatase inhibitor (AI) therapy with TRT. Exogenous testosterone’s contraceptive effect occurs through its suppression of the HPG axis, preventing LH and FSH release and their respective gonadal functions (11). Low ITT levels result in an impaired blood-testis barrier permitting immune cells to enter the seminiferous tubules and attack autoantigenic germ cells reviewed by Walker (8). Unsurprisingly, inactivating mutations of the FSHR and LHR results in impaired fertility (3,4).|This hormonal imbalance disrupts intratesticular testosterone concentrations vital for sperm maturation, consequently contributing to fertility decline. Exogenous testosterone administration inhibits gonadotropin-releasing hormone (GnRH) secretion, reducing luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels, critical regulators of testicular function. TRT alone suppresses the hypothalamic-pituitary-gonadal axis, reducing intratesticular testosterone and impairing spermatogenesis. In our opinion, hypogonadal men seeking treatment without side effects on fertility should first consider HCG or clomiphene treatment. In the case of primary hypogonadism, post-cycle therapy might not be effective in restoring HPGA functions; therefore, freezing sperm is especially important in these individuals before starting TRT. Also, in the case of injectable [buy testosterone online no prescription](https://aiviu.app/@kellibeet1528?page=about) medications, before initiating TRT, it is recommended to freeze sperm at a sperm bank or fertility clinic. The duration of fertility recovery seems to be dependent on the dosage and length of the [buy testosterone online](http://175.27.229.211:3000/gabriellacurts) treatment.|Safety monitoring recommendations for men on testosterone therapy Clinically, most men on standard TRT develop azoospermia or severe oligospermia within three to six months. Understanding the physiology of suppression and the window of reversibility is the first step toward protecting spermatogenesis while maintaining hormonal health. In the United States alone, more than 3 million men are now using injectable testosterone formulations for clinically diagnosed hypogonadism.} Start by finding a qualified clinician who is knowledgeable in testosterone therapy. For example, some healthcare professionals require a well-documented history of gender dysphoria before prescribing or approving gender affirming interventions like hormone therapy. Your clinician may also have certain requirements before they will allow you to move forward with testosterone therapy. If you’re under age 18, you may be able to receive testosterone therapy with parental consent. Generally speaking, access to gender affirming care — which includes testosterone therapy — is limited to consenting adults ages 18 and older. Learn about the connection between infertility and age. The risk of infertility increases as you age. Infertility is a condition where you can’t get pregnant after one year of trying to conceive. Availability, access, and quality of interventions to address infertility remain a challenge in most countries. Only a healthcare provider can determine the cause and find the best treatment for you. Fortunately, there are many treatment options available for women who wish to begin or expand their family. Infertility is more common than you might think. A pregnancy can’t occur if anything in this process doesn’t happen. Infertility can affect anyone and has many causes. WHO recognizes that the provision of high-quality services for family-planning, including fertility care services, is one of the core elements of reproductive health. Once fertility policies are in place, it is essential to ensure that their implementation is monitored, and the quality of services is continually improved. Spermatogenesis depends on the pulsatile release of gonadotropins, follicle stimulating hormone (FSH), and luteinizing hormone (LH), from the pituitary, and their action on their cells in the testis. Male fertility and proper functioning of the HPG axis are closely intertwined. Some therapeutic strategies may even enhance the fertility potential of men with certain diagnoses. In male patients, even though promising results have been published, the usage of SERMs remains off-label. In this case, the addition of testosterone would negatively impact semen parameters. Therefore, if HCG is available, HCG alone should be used first, and the addition of testosterone should only be considered if serum testosterone does not increase to the target level. After [buy testosterone online without prescription](http://113.177.27.200:2033/vernlambert121) administration, LH and FSH were inhibited to 5% and 3% of baseline, respectively, and ITT was downregulated by 94% (1234 to 72 nmol/L) in the [buy testosterone supplements](http://www.flop.jp.org/bbs_font/bbs.cgi)/placebo group. The baseline serum testosterone level (14.1 nmol/L) was only 1.2% of the ITT level (1174 nmol/L). In addition, enabling laws and policies that regulate third party reproduction and ART are essential to ensure universal access without discrimination and [https://employ.co.il/](https://employ.co.il/employer/the-molecular-mechanism-of-sex-hormones-on-sertoli-cell-development-and-proliferation/) to protect and promote the human rights of all parties involved. Government policies could mitigate the many inequities in access to safe and effective fertility care. Infertility has significant negative social impacts on the lives of infertile couples and particularly women, who frequently experience violence, divorce, social stigma, emotional stress, depression, anxiety and low self-esteem. Inequities and disparities in access to fertility care services adversely affect the poor, unmarried, uneducated, unemployed and other marginalized populations. Infertility can negate the realization of these essential human rights (3). This preserves testicular stimulation while maintaining serum testosterone levels sufficient to relieve hypogonadal symptoms. Clinical studies from Fertility and Sterility (2024) and The Journal of Urology (2025) demonstrate that HCG co-therapy can preserve sperm counts in men receiving exogenous testosterone. It binds to LH receptors on Leydig cells, stimulating them to produce testosterone inside the testes maintaining the intratesticular concentration necessary for sperm production. Discussing it early allows clinicians and patients to plan interventions such as adding low-dose HCG during TRT to protect spermatogenesis without compromising symptom control. The American Urological Association’s 2025 update emphasizes that fertility preservation is part of informed consent for testosterone therapy.